LONDON (ShareCast) - Admiral: Oriel Securities retains sell rating and 740p target.

AstraZeneca: Panmure Gordon maintains buy rating and 3,600p target.

Barclays: Nomura reiterates neutral rating and 268p target; Exane BNP Paribas keeps outperform rating and 300p target; Oriel Securities keeps buy rating and 285p target; Seymour Pierce keeps hold rating and 200p target; Investec keeps buy rating and 240p target.

Berendsen: Seymour Pierce downgrades from buy to add, 545p target kept.

Capita: UBS cuts target from 725p to 700p, neutral rating kept.

Dixon Retail: AlphaValue downgrades to from buy to add, raises target to €21.30 from €21.20.

Howden Joinery: Espirito Santo reiterates buy recommendation and 150p target.

HSBC: Exane BNP Paribas keeps outperform rating and 675p target.

GlaxoSmithKline: Panmure Gordon reiterates hold rating and 1,450pt argot.

Go-Ahead Group: Panmure Gordon cuts target from 1,450p to 1,250p, hold recommendation kept.

Ladbrokes: Nomura raises target from 135p to 150p, neutral rating unchanged.

Lloyds: Exane BNP Paribas keeps outperform rating and and 45p target.

UBM: Nomura ups target from 665p to 675p, buy rating kept.

Unilever: Panmure Gordon reiterates buy rating and 2,300p target.

Whitbread: Panmure Gordon maintains hold rating and 1,768p target; Shore Capital maintains buy rating.

William Hill: Nomura lifts target from 190p to 205p, reduce rating unchanged.

BC

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE